Does Glutathione Lighten Skin? UK Law and the Evidence
In this article
No glutathione medicine is licensed in the UK, and the drips and injections sold for skin lightening are unlicensed uses which, in the MHRA's 2016 wording, meet no "admissible special need". The oral trials are small and short, four to twelve weeks; reviews call the evidence "inconclusive" and the effect "unsustainable"; and no trial measured anyone's skin after stopping. Ask a GP, a dermatologist or a pharmacist. Glutathione has no authorised health claim in the UK.1 No dose, timeline or product appears here, for reasons below; the ingredient itself is on what does glutathione do in the body.
Sources checked on 1 November 2026.
Is glutathione licensed for skin lightening in the UK?
No. No glutathione product holds a UK marketing authorisation. The MHRA's guidance on unlicensed medicines (updated 29 January 2025) says they may be supplied only "when there are no licensed available medicines that can meet the needs of individual patients", needs that "must be clinical in nature and are determined by the prescriber responsible for their care".2 The Joint Council for Cosmetic Practitioners carries the MHRA's 2016 position on "strictly cosmetic" indications: "Special needs must be medical in nature and unable to be met by an available equivalent licensed product. Cosmetic use is therefore not an admissible special need."3
A drip or injection sold for lightening in the UK is therefore an unlicensed medicine given for a purpose the regulator has ruled out. The Chartered Trading Standards Institute's warning of 26 June 2025 said these procedures "remain entirely unregulated in the UK" and advised: "Never undergo IV drip procedures outside of a regulated medical setting".4 The MHRA's advice on one imported glutathione injection, on the Joint Council's page, is that it "does not possess a Marketing Authorisation for use in the UK".3 The full picture is on are glutathione injections and drips safe in the UK.
Oral glutathione sold as a food supplement is lawful but may carry no lightening claim, or any health claim: "Only authorised claims in the Great Britain NHC register may be used in Great Britain", and the register has no glutathione entry.1 Creams and serums come under cosmetics law, and a UK border check found banned ingredients in a lotion labelled with glutathione: both below.5
What have the trials of glutathione for skin actually shown?
Five small trials, four to twelve weeks long, measured a melanin index with a skin instrument; the table gives each one's size, length, finding as stated, and whether anyone was measured after stopping.
| Study | People, length | What was given | Finding, as stated | Measured after stopping |
|---|---|---|---|---|
| Thailand, 20126 | 60 medical students, 4 weeks | 500 mg a day by mouth, against placebo | Melanin index fell more than placebo at two of six sites (p = 0.021, 0.036); lightening "in a small number of subjects"; "long-term safety has not been established" | No |
| Thailand, 20177 | 60 women enrolled, 57 analysed, 12 weeks | 250 mg a day, reduced or oxidised form, against placebo; supplier-funded | Melanin index "tended to be lower than placebo", not statistically significant (p > 0.05); two withdrawals for raised liver tests, neither in the reduced-glutathione group, normal again within weeks | No |
| Sponsor trial, 20228 | 124 Asian women, 12 weeks | 250 mg a day alone, against a cystine-and-glutathione combination, cystine alone, or placebo | The sponsor's combination did more than glutathione alone; glutathione-alone figures not reported | No |
| Philippines, 20169 | 30 women, 8 weeks | A daily lozenge combining glutathione with selenium, vitamins C, D3 and E and grape seed extract25 | Melanin index fell from baseline; no placebo group; supplier-funded | No |
| Company trial, 201410 | 30 women, 10 weeks | 2% oxidised-glutathione lotion on one side of the face, placebo the other | Melanin index lower on the treated side at 10 weeks (p < 0.001) | No |
The 2025 systematic review judged that "almost an equal number of studies have low and high risk of bias", called the oral and topical findings "unsustainable", found one placebo-controlled intravenous study (6 of 16 responders against 3 of 16, p = 0.054, not significant), and said "IV glutathione is contraindicated due to lack of efficacy and side effects".11 A 2019 systematic review found changes only on sun-exposed skin and called the evidence "still inconclusive".12 A 2016 review found "no evidence to prove" intravenous efficacy and said "key questions such as the duration of treatment, longevity of skin-lightening effect and maintenance protocols remain unanswered".13 A 2018 review described the oral and topical findings as "appreciable but reversible".14 The 12-week trial's wrinkle findings are on does glutathione make you look younger.
Why does this page give no dose, timeline or product?
Because nothing in the record supports one: there is no licensed use to take a dose from, no trial ran longer than twelve weeks or followed anyone after stopping, and the reviews' words for how long any effect lasts are "remain unanswered".13 The amounts in the table are what those studies gave, not an instruction; a UK food supplement may not claim lightening at any amount.1 Labels and combinations are on how to take glutathione and can I take collagen and glutathione together.
What harms have been reported, and from which route?
Capsules and lozenges. The oral trials report no serious adverse effects: "very well tolerated" at four weeks, "no serious adverse effects" at twelve, normal laboratory findings in the lozenge study.6, 7, 9 The two withdrawals for raised liver tests are the one laboratory signal, settled within weeks, and neither was in the reduced-glutathione group.7 Stomach upset, and the cautions for pregnancy, children and asthma, are on glutathione side effects.
Injections and drips. A 2025 narrative review said intravenous glutathione "is associated with serious safety concerns like anaphylaxis and hepatotoxicity".15 The 2016 review records the Philippine regulator's "public warning condemning its use for off-label indications such as skin lightening".13 The 2026 review lists "hepatotoxicity, hypersensitivity reactivity, and potential renal and endocrine effects" as concerns.16 The Trading Standards warning relayed a campaign group's account of consumer reports of "anaphylaxis requiring hospitalisation, kidney strain and infections"; reports, not trial counts.4
Who should you ask?
Three people. A GP; of cosmetic procedures the NHS says "A GP or mental health professional might be a good place to start".17 A dermatologist, for pigmentation, dark patches or uneven tone; the NHS says "You should check if someone is a registered doctor or surgeon on the General Medical Council online register".18 A pharmacist, with the label of anything you take. Report a reaction to an injection or drip through the Yellow Card scheme, and one to a swallowed supplement to your local authority's food safety team, which works with the Food Standards Agency; call NHS 111 if you need medical help, and 999 for the anaphylaxis signs the NHS lists, among them "swelling of your throat and tongue" and "difficulty breathing or breathing very fast".4, 19, 20
What we don't know
- Whether any lightening lasts: no trial measured skin after stopping.13
- Long-term safety by mouth: the trials ran four to twelve weeks, and the 2012 authors wrote that "long-term safety has not been established".6
- How often injection harms happen: the record is reviews and consumer reports, not counts from trials.4, 15, 16
Frequently asked questions
Is glutathione skin lightening permanent?
No trial followed anyone after stopping, so no study can call it permanent. The reviews describe the oral and topical results as "appreciable but reversible" (2018) and "unsustainable" (2025), and the 2016 review said duration and maintenance "remain unanswered".11, 13, 14
Will I go darker if I stop taking glutathione?
No study has measured skin after stopping, so nothing can be said from evidence. What has been measured: the lightening is described as reversible, and blood glutathione itself "returned to baseline after a 1-month washout period" in the six-month trial of 54 adults, while a supplier-funded four-week trial of 40 adults found it unchanged.14, 21, 22
Is glutathione skin whitening safe, and is there an injection for it?
No study has established that, by any route. Swallowed: the trials report no serious adverse effects over four to twelve weeks, two withdrawals for raised liver tests in one trial, and the 2012 authors' own words, "long-term safety has not been established".6, 7 Injected: drips and injections are sold for it, an unlicensed use the MHRA calls "not an admissible special need"; the one placebo-controlled study was not significant, the reviews report anaphylaxis and liver toxicity, and the 2025 systematic review says "contraindicated".3, 11, 15 Ask a GP, dermatologist or pharmacist before either.
Can glutathione lighten dark spots or melasma?
Dark patches, melasma and other pigmentation changes have several causes; see a GP or a dermatologist. The one trial that measured facial dark spots, in 124 women, attributes the reduction to the sponsor's cystine-and-glutathione combination, not to glutathione alone.8
Do glutathione creams or serums work, and are they legal in the UK?
Lawful to sell as cosmetics; the evidence is one short trial. A cosmetic needs no licence, but it "shall be safe for human health" and its labelling and advertising "shall not be used to imply that these products have characteristics or functions which they do not have".23 Anything "presented as having properties of preventing or treating disease" is a medicine, and no glutathione medicine is licensed here; the MHRA and Trading Standards wording above concerns injections and drips.24, 2 The safety question is the jar's contents: the border report found 3.1% hydroquinone and two prescription corticosteroids, prohibited in cosmetics, in a whitening lotion labelled with glutathione.5 The one trial gave 30 women a 2% oxidised-glutathione lotion on one side of the face and placebo on the other for ten weeks: a lower melanin index on the treated side, "no marked adverse effects", authors employed by the maker, nothing measured after stopping.10 Take the ingredient list to a pharmacist or GP, especially for anything bought online or abroad.
Sources
- GOV.UK. Great Britain nutrition and health claims register, last updated 19 May 2026. gov.uk.
- MHRA. Supply unlicensed medicinal products (specials), updated 29 January 2025. gov.uk.
- Joint Council for Cosmetic Practitioners. Glutathione and unlicensed medicines used in cosmetic procedures; practitioner guidance carrying the MHRA 2016 wording, read 1 November 2026. jccp.org.uk.
- Chartered Trading Standards Institute. Public warning on glutathione IV drips, 26 June 2025. tradingstandards.uk.
- Office for Product Safety and Standards. Product Safety Report 2301-0119, 2023. gov.uk.
- Arjinpathana N, Asawanonda P. J Dermatolog Treat, 2012. Randomised double-blind placebo-controlled trial, 60 medical students, four weeks. PubMed 20524875.
- Weschawalit S, et al. Clin Cosmet Investig Dermatol, 2017. Randomised double-blind placebo-controlled trial, 60 women, 12 weeks; funded by the glutathione supplier. PubMed 28490897.
- Duperray J, et al. J Cosmet Dermatol, 2022. Randomised double-blind placebo-controlled trial, 124 women, 12 weeks; funded by the maker of the combination. PubMed 33834608.
- Handog EB, et al. Int J Dermatol, 2016. Open-label single-arm trial, 30 women, eight weeks; company-funded. PubMed 26148180.
- Watanabe F, et al. Clin Cosmet Investig Dermatol, 2014. Randomised double-blind split-face trial, 30 women, 10 weeks; three of four authors employed by the glutathione maker. PubMed 25378941.
- Sarkar R, et al. Systematic review of ten years of studies. Int J Dermatol, 2025. PubMed 39444151.
- Dilokthornsakul W, et al. Systematic review, four studies. J Cosmet Dermatol, 2019. PubMed 30895708.
- Sonthalia S, et al. Indian J Dermatol Venereol Leprol, 2016. Narrative review. PubMed 27088927.
- Sonthalia S, et al. Dermatol Pract Concept, 2018. Narrative review; no conflicts declared. PubMed 29445569.
- Alzahrani TF, et al. Narrative review. Cureus, 2025. PubMed 40013212.
- Aloraini K, et al. Narrative review. J Med Life, 2026. PubMed 42751591.
- NHS. Before you have a cosmetic procedure, last reviewed 22 May 2023 (review overdue). nhs.uk.
- NHS. Choosing who will do your cosmetic procedure, last reviewed 23 June 2023 (review overdue). nhs.uk.
- GOV.UK. Yellow Card scheme. gov.uk. Food Standards Agency. How to report a food safety or hygiene issue for members of the public, updated 5 August 2026. gov.uk.
- NHS. Anaphylaxis, last reviewed 21 June 2023 (review overdue). nhs.uk.
- Richie JP, et al. Eur J Nutr, 2015. Randomised placebo-controlled trial, 54 adults completed, six months. PubMed 24791752.
- Allen J, Bradley RD. J Altern Complement Med, 2011. Randomised placebo-controlled trial, 40 adults, four weeks; funded by the glutathione supplier. PubMed 21875351.
- Cosmetics Regulation (EC) No 1223/2009, retained UK law, Articles 3 and 20. legislation.gov.uk.
- MHRA. Borderline products: how to tell if your product is a medicine, last updated 2 July 2026. gov.uk.
- EFSA NDA Panel. Safety of S-acetyl glutathione as a novel food. EFSA Journal, 2026. Scientific opinion, adopted 2 July 2026, reviewing the oral glutathione trials. PubMed 42683004.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
General information, not medical advice. For pigmentation changes see a GP or a dermatologist; take any label to a pharmacist.